MedWorld Advisors announces the formation of the MedTech Laser Group

International healthcare M&A advisory firm MedWorld Advisors has announced the formation of the MedTech Laser Group via the acquisition of shares of A.R.C Laser GmbH, a German company based in Nuremberg, and of G.N.S. neoLaser Ltd. an Israeli company based in Caesarea, by Afinum 9, advised by Afinum Management GmbH, based in Munich, Germany. 

A.R.C. Laser, a private, family-owned enterprise established in 1996, has a long-standing history as a pioneering platform in medical laser technology development. The company offers an extensive range of innovative laser technologies focused on ophthalmic treatments, particularly for glaucoma and cataract procedures.

The company has since diversified its product portfolio to include surgical applications e.g. in Laryngology, Otology, Rhinology, as well as Veterinary medicine. 

neoLaser, also privately owned, was founded in 2012 and is a specialist in laser systems and fibres for Endovenous Laser Ablation and applications in Proctology. According to MedWorld Advisors, neoLaser’s advanced laser solutions have positioned it as a leader in its respective fields, driving significant advancements in patient care and treatment outcomes.

Afinum, an independent investment firm focusing on small and medium-sized companies, has been active since 2000. Focusing on four tech enabled verticals: Healthcare, Industrial Technology, Software & TMT and Consumer & Internet, Afinum partners with entrepreneurs to develop companies to their full potential.

This transaction marks the tenth platform investment of the Afinum 9 fund and the third thematic investment in the MedTech sector. 

In this partnership, the founders of A.R.C Laser and neoLaser will jointly invest in the formation of this integrated medical laser technology company. As part of the transaction, Afinum acquires a significant majority stake while the founders re-invest in the newly formed entity.

The global market for ophthalmologic and surgical lasers is poised for substantial growth according to MedWorld, driven by various secular trends such as aging population, increasing prevalence of relevant diseases, and technological advancements in laser treatments driving adoption across medical disciplines. This market opportunity underscores the strategic rationale behind the formation of the MedTech Laser Group, aimed at capitalising on these growth drivers to deliver innovative medical solutions. 

Under the umbrella of the MedTech Laser Group, A.R.C. Laser and neoLaser will be able to jointly capitalise on this market opportunity according to the group. The partnership is designed to harness synergies for further topline growth. The companies will continue to operate as independent entities while leveraging their combined strengths to collaborate on research and development, sales and marketing, as well as regulatory matters.

The advisors say the joint growth strategy will emphasise international expansion, an enhanced go to market approach and further driving organisational development, as the group broadens its technology and product portfolio organically and potentially through strategic add-on acquisitions.